GlassScriptPhysician profile
Kurt W Rode
NPI 1740591072
$2,883.44
in general payments reported to CMS, 2019-2025
9 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what 82% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.93 · 2020: $301 · 2021: $225 · 2022: $760 · 2023: $153 · 2024: $282 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Travel and Lodging: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.74 |
| Travel and Lodging | $766.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,588.35 | 2022-2025 | |
| Smith+Nephew, INC. | $384.06 | 2020-2025 | Panta 2, Small Cannulated Screws, Cannulated Screws |
| Zimmer Biomet Holdings, INC. | $266.63 | 2020-2021 | |
| Davol INC. | $191.04 | 2020 | |
| Stryker Corporation | $147.66 | 2024 | Augment Injectable |
| Triad Life Sciences INC. | $141.95 | 2022 | |
| Paragon 28, INC. | $119.99 | 2025 | Ankle Fracture |
| Ossio INC | $27.83 | 2020 | |
| Merck Sharp & Dohme LLC | $15.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Rode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.